Editas Medicine, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sale | 1,752 | $8.16 | $14,296 | 80,530 | Jan 10, 2023 |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sale | 193 | $10.23 | $1,974 | 82,282 | Dec 5, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 102 | $10.23 | $1,043 | 64,636 | Dec 5, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 289 | $11.02 | $3,185 | 64,738 | Nov 8, 2022 |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sale | 192 | $15.01 | $2,882 | 82,475 | Sep 6, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 101 | $15.01 | $1,516 | 65,027 | Sep 6, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 293 | $18.60 | $5,450 | 65,128 | Aug 9, 2022 |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Award / Grant | 58,372 | — | — | 58,372 | Jul 18, 2022 |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Sale | 5,145 | $10.06 | $51,759 | 68,349 | Jun 15, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 1,123 | $11.54 | $12,959 | 65,421 | Jun 3, 2022 |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sale | 1,527 | $11.54 | $17,622 | 82,667 | Jun 3, 2022 |
| O'Neill Gilmore Neil | CEO | Award / Grant | 86,655 | — | — | 86,655 | Jun 2, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 297 | $13.11 | $3,894 | 66,544 | May 9, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 403 | $17.33 | $6,984 | 68,386 | Mar 3, 2022 |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sale | 767 | $17.33 | $13,292 | 84,194 | Mar 3, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Award / Grant | 37,593 | — | — | 68,789 | Feb 10, 2022 |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Award / Grant | 31,709 | — | — | 73,494 | Feb 10, 2022 |
| ROBERTSON MICHELLE | CHIEF FINANCIAL OFFICER | Award / Grant | 53,499 | — | — | 84,961 | Feb 10, 2022 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 302 | $17.63 | $5,324 | 31,196 | Feb 8, 2022 |
| ROBERTSON MICHELLE | Chief Financial Officer | Sale | 1,744 | $25.70 | $44,821 | 31,462 | Jan 11, 2022 |
| MULLEN JAMES C | CEO | Sale | 18,252 | $26.95 | $491,891 | 75,898 | Jan 3, 2022 |
| Eaton Bruce | EVP, Chief Business Officer | Award / Grant | 3,472 | — | — | 31,498 | Dec 22, 2021 |
| Michaels Lisa Anne | EVP/Chief Medical Officer | Award / Grant | 4,243 | — | — | 22,675 | Dec 22, 2021 |
| Shearman Mark S | EVP, Chief Scientific Officer | Award / Grant | 9,084 | — | — | 41,785 | Dec 22, 2021 |
| ROBERTSON MICHELLE | Chief Financial Officer | Award / Grant | 4,471 | — | — | 33,206 | Dec 22, 2021 |
| MULLEN JAMES C | CEO | Award / Grant | 36,477 | — | — | 94,150 | Dec 22, 2021 |
| Michaels Lisa Anne | EVP/Chief Medical Officer | Sale | 1,568 | $38.33 | $60,101 | 18,432 | Nov 12, 2021 |
| Eaton Bruce | EVP, Chief Business Officer | Sale | 287 | $40.61 | $11,655 | 28,026 | Nov 9, 2021 |
| MULLEN JAMES C | CEO | Sale | 13,805 | $38.03 | $525,004 | 57,673 | Oct 18, 2021 |
| MULLEN JAMES C | CEO | Award / Grant | 36,478 | — | — | 71,478 | Sep 30, 2021 |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sale | 1,258 | $19.64 | $24,707 | 66,841 | Aug 9, 2021 |
| ROBERTSON MICHELLE | Chief Financial Officer | Sale | 2,500 | $60.00 | $150,000 | 28,735 | Aug 9, 2021 |
| ROBERTSON MICHELLE | Chief Financial Officer | Sale | 2,500 | $50.00 | $125,000 | 28,735 | Jun 28, 2021 |
| Shearman Mark S | EVP, Chief Scientific Officer | Award / Grant | 32,701 | — | — | 32,701 | Jun 14, 2021 |
| Hopfield Jessica | — | Purchase | 5,800 | $45.51 | $263,958 | 22,700 | Mar 3, 2021 |
| ROBERTSON MICHELLE | Chief Financial Officer | Award / Grant | 10,303 | — | — | 28,735 | Mar 2, 2021 |
| MULLEN JAMES C | CEO | Purchase | 25,000 | $46.27 | $1,156,750 | 35,000 | Mar 2, 2021 |
| Collins Cynthia | CEO | Sale | 1,262 | $66.65 | $84,112 | 43,760 | Feb 9, 2021 |
| ROBERTSON MICHELLE | Chief Financial Officer | Sale | 1,568 | $78.27 | $122,727 | 18,432 | Jan 12, 2021 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 200 | $64.39 | $12,878 | 24,907 | Dec 15, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 10,000 | $45.00 | $450,000 | 24,907 | Dec 9, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 20,000 | $40.02 | $800,400 | 24,907 | Dec 7, 2020 |
| Michaels Lisa Anne | EVP/Chief Medical Officer | Award / Grant | 20,000 | — | — | 20,000 | Nov 9, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 228 | $31.21 | $7,116 | 24,907 | Nov 9, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 3,000 | $31.39 | $94,170 | 25,135 | Oct 15, 2020 |
| Collins Cynthia | CEO | Sale | 1,976 | $36.66 | $72,440 | 45,022 | Aug 20, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Option Exercise | 10,000 | $16.51 | $165,100 | 38,135 | Aug 17, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 238 | $34.99 | $8,328 | 28,135 | Aug 6, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 3,000 | $32.22 | $96,660 | 28,373 | Jul 15, 2020 |
| Albright Charles | EVP/Chief Scientific Officer | Sale | 151 | $25.28 | $3,817 | 31,373 | May 6, 2020 |